Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)

NCT07565467 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT07565467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07565467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)
Lead sponsor
M.D. Anderson Cancer Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 8, 2026
Completion date
March 1, 2033
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

act-gen, genetic cancer syndromes